Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug ...

India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

A day after logging their biggest single-day gain in over four years, Indian benchmarks cooled off on Tuesday as traders ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

The Indian Pharmaceutical Alliance (IPA) emphasizes the need to balance innovation with affordability in response to ...

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

Cipla CEO says US order to lower drug prices won't impact Indian generic drugmakers. The order is likely to target branded ...